Indian Army Department Of Military Affairs Pharmaceutical Tender Pithoragarh Uttarakhand 2025
Bid Publish Date
02-Nov-2025, 10:41 am
Bid End Date
12-Nov-2025, 11:00 am
Value
₹40,396
Location
Progress
Quantity
30380
Category
Cilnidipine 5 mg tab
Bid Type
Two Packet Bid
Categories
6
Tender Overview
Organization: Indian Army, Department Of Military Affairs, procuring a multi-item pharmaceutical package including Cilnidipine 5 mg tab, Frusemide 20 mg, antacid chewables, methyl polysiloxane, trypsin/chymotrypsin, Hyoscine bromide inj, Norflox + tinidazole, ORS sachets, Misoprostol, Thyroxin, and other listed tablets. Estimated value: ₹40,396. Location: PITHORAGARH, UTTARAKHAND - 262501. Quantity/Scope: 10 items in BoQ; unit quantities not specified. Key differentiator lies in the diverse pharmaceutical mix under government procurement. Unique term includes an option clause enabling ±25% variation in ordered quantity and extended delivery periods. This tender targets qualified pharmaceutical suppliers capable of supplying a broad range of medicines for military medical needs.
Technical Specifications & Requirements
- No explicit technical specifications or standards provided in the tender data.
- BoQ lists 10 items (drug/tablet forms, injections, sachets) with no unit quantities disclosed.
- Procurement category falls under pharmaceutical/medical supplies for defense use; the absence of IS/ISO requirements suggests generic compliance with standard drug regulations.
- Buyer terms include an option to adjust quantity by ±25% and to extend delivery time proportionally, with minimum 30 days for additional time; delivery timing tied to original and extended delivery orders.
- No EMD amount specified; no explicit brand/OEM constraints documented.
Terms, Conditions & Eligibility
- Quantity variation: Purchaser may increase/decrease quantity up to 25% at contract placement and during currency at contracted rates.
- Delivery timeline: Additional delivery time calculated as (additional quantity / original quantity) × original delivery period, minimum 30 days.
- Delivery commencement: From the last date of the original delivery order; extended period follows the same logic.
- Documentation: Terms require bidder compliance with the option clause; no specific EMD, GST, or experience thresholds stated in the provided data.
Key Specifications
-
Product/service names: Cilnidipine 5 mg tablet; Frusemide 20 mg; Antacid chewable (Aluminium hydroxide IP 250 mg, Hydrozine NF 250 mg, Methyl polysiloxane 50 mg); Trypsin-Chymotrypsin (Chymoral Forte) tablet; Hyoscine bromide injection 20 mg/mL; Norfloxacin 400 mg + Tinidazole 500 mg tablet; ORS sachet 20.5 g (NaCl IP 2.6 g, dextrose IP 13.5 g, KCl); Misoprostol 25 mcg; Thyroxine 50 mcg; Misoprostol 100 mcg tablet.
-
Quantities/values: Total items = 10; specific unit quantities not disclosed.
-
Standards/ Certifications: Not specified in tender data; no IS/ISO codes listed.
-
Delivery/ installation: No installation details; delivery terms governed by option clause and delivery extension formula.
-
Quality/testing: No explicit testing or QA standards mentioned.
Terms & Conditions
-
Option Clause: +/- 25% quantity variation at contract/extension
-
Delivery: Additional time = (extra quantity / original quantity) × original period, min 30 days
-
Delivery start: from last date of original delivery order; extensions follow same rule
Important Clauses
Payment Terms
Not disclosed in provided data; bidders should await final terms in tender document.
Delivery Schedule
Delivery period can be extended with option clause; extended time calculation specified with minimum 30 days.
Penalties/Liquidated Damages
Not specified in the data; bidders should review final contract terms for LD provisions.
Bidder Eligibility
-
Experience in supplying pharmaceutical items to government or defense sectors
-
Adequate financial capacity to support multi-item medicinal procurement
-
Compliance with drug regulatory standards and documented quality controls
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Cilnidipine 5 mg tab , Frusemide 20mg 2 ml inj , Antacid chewable containing dried aliminium hydroxide ip 250mg hydrodixe Nf 250 mg Methyl polysilodxane 50 mg tab , Trypsin chymotrypsin tab chymoral forte tab , Hyoscine bromide inj 20 mg ml 1ml inj , Norflox 400 mg plus tinidazole 500 mg tab , Oral rehydration powder sachet of 20.5 g each containing sodium chloride IP 2.6 g anhydrous dextrose ip 13.5 g potasium chloride , Tab Misoprostol 25 mcg , Tab Thyroxin 50 mcg , Misoprostol 100 mcg tab
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 4
GeM-Bidding-8539889.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
10 Items Sign in to view GEM price trends Sign in for GEM prices
Cilnidipine 5 mg tab
Cilnidipine 5 mg tab
Frusemide 20mg 2 ml inj
Frusemide 20mg 2 ml inj
Antacid chewable containing dried aliminium hydroxide ip 250mg hydrodixe Nf 250 mg Methyl polysilodxane 50 mg tab
Antacid chewable containing dried aliminium hydroxide ip 250mg hydrodixe Nf 250 mg Methyl polysilodxane 50 mg tab
Trypsin chymotrypsin tab chymoral forte tab
Trypsin chymotrypsin tab chymoral forte tab
Hyoscine bromide inj 20 mg ml 1ml inj
Hyoscine bromide inj 20 mg ml 1ml inj
Norflox 400 mg plus tinidazole 500 mg tab
Norflox 400 mg plus tinidazole 500 mg tab
Oral rehydration powder sachet of 20.5 g each containing sodium chloride IP 2.6 g anhydrous dextrose ip 13.5 g potasium chloride
Oral rehydration powder sachet of 20.5 g each containing sodium chloride IP 2.6 g anhydrous dextrose ip 13.5 g potasium chloride
Tab Misoprostol 25 mcg
Tab Misoprostol 25 mcg
Tab Thyroxin 50 mcg
Tab Thyroxin 50 mcg
Misoprostol 100 mcg tab
Misoprostol 100 mcg tab
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Cilnidipine 5 mg tab | Cilnidipine 5 mg tab | 1,400 | no | consignee2@161mh | 15 | |
| 2 | Frusemide 20mg 2 ml inj | Frusemide 20mg 2 ml inj | 1,000 | amp | consignee2@161mh | 15 | |
| 3 | Antacid chewable containing dried aliminium hydroxide ip 250mg hydrodixe Nf 250 mg Methyl polysilodxane 50 mg tab | Antacid chewable containing dried aliminium hydroxide ip 250mg hydrodixe Nf 250 mg Methyl polysilodxane 50 mg tab | 6,000 | no | consignee2@161mh | 15 | |
| 4 | Trypsin chymotrypsin tab chymoral forte tab | Trypsin chymotrypsin tab chymoral forte tab | 7,200 | no | consignee2@161mh | 15 | |
| 5 | Hyoscine bromide inj 20 mg ml 1ml inj | Hyoscine bromide inj 20 mg ml 1ml inj | 200 | amp | consignee2@161mh | 15 | |
| 6 | Norflox 400 mg plus tinidazole 500 mg tab | Norflox 400 mg plus tinidazole 500 mg tab | 2,000 | no | consignee2@161mh | 15 | |
| 7 | Oral rehydration powder sachet of 20.5 g each containing sodium chloride IP 2.6 g anhydrous dextrose ip 13.5 g potasium chloride | Oral rehydration powder sachet of 20.5 g each containing sodium chloride IP 2.6 g anhydrous dextrose ip 13.5 g potasium chloride | 1,500 | sachet | consignee2@161mh | 15 | |
| 8 | Tab Misoprostol 25 mcg | Tab Misoprostol 25 mcg | 480 | no | consignee2@161mh | 15 | |
| 9 | Tab Thyroxin 50 mcg | Tab Thyroxin 50 mcg | 10,000 | no | consignee2@161mh | 15 | |
| 10 | Misoprostol 100 mcg tab | Misoprostol 100 mcg tab | 600 | no | consignee2@161mh | 15 |
Required Documents
GST registration certificate
Permanent Account Number (PAN) card
Experience certificates showing prior procurement of pharmaceutical items
Financial statements or bankers' certificates demonstrating financial capacity
EMD/Security deposit documentation (if applicable per final tender terms)
Technical bid documents and product compliance declarations
OEM authorizations or dealership certificates for listed medicines
Any certifications relating to pharmaceutical quality control
Technical Results
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ARORA BROS MEDILINKERS Under PMA | - | 11-11-2025 17:40:56 | |
| 2 | B LAL & SONS Under PMA | - | 11-11-2025 15:36:07 | |
| 3 | DEEKNISC SERVICES & SOLUTIONS PRIVATE LIMITED Under PMA | - | 11-11-2025 12:35:47 | |
| 4 | FASTCARE PHARMA Under PMA | - | 10-11-2025 16:24:26 | |
| 5 | H R ENTERPRISES Under PMA | - | 11-11-2025 19:18:39 | |
| 6 | JSHREE MEDITECH SYSTEM Under PMA | - | 12-11-2025 09:32:20 | |
| 7 | KANDA ENTERPRISES Under PMA | - | 06-11-2025 11:41:52 | |
| 8 | KUNDAN LIFESCIENCES Under PMA | - | 04-11-2025 18:11:03 | |
| 9 | NUTRAKEM INDIA PRIVATE LIMITED Under PMA | - | 04-11-2025 18:55:06 | |
| 10 | NUYOS HEALTHCARE PRIVATE LIMITED Under PMA | - | 12-11-2025 06:28:42 | |
| 11 | PRATHMESH DISTRIBUTOR Under PMA | - | 11-11-2025 15:02:50 | |
| 12 | SIXTEEN DIRECTIONS HOMECARE PRIVATE LIMITED Under PMA | - | 12-11-2025 09:19:57 | |
| 13 | SRI SAI AGENCIES Under PMA | - | 07-11-2025 16:51:57 | |
| 14 | SUNIL PHARMACY Under PMA | - | 12-11-2025 10:02:45 | |
| 15 | VINOD AGENCIES Under PMA | - | 11-11-2025 16:41:53 |
Frequently Asked Questions
Key insights about UTTARAKHAND tender market
How to bid in the Indian Army pharmaceutical tender in Pithoragarh?
Bidders must submit GST, PAN, experience certificates, financials, EMD, technical compliance, and OEM authorizations as per terms. The tender allows +/-25% quantity variation and requires adherence to delivery conditions including minimum 30 days for extended delivery. Ensure you meet defense procurement documentation standards.
What documents are required for this pharma tender in Uttarakhand?
Required documents include GST certificate, PAN, experience certificates in supplying medicines, financial statements, EMD/Security deposit, technical bid, OEM authorizations, and any drug regulatory compliance certificates. Prepare these before submission to avoid disqualification.
What items are included in the BoQ for this army tender?
The BoQ lists 10 drug items: Cilnidipine 5 mg tablets, Frusemide 20 mg, antacid chewable with aluminium hydroxide/IP components, methyl polysiloxane, Trypsin-Chymotrypsin (Chymoral Forte), Hyoscine bromide injection, Norfloxacin 400 mg + Tinidazole 500 mg tablet, ORS sachet 20.5 g, Misoprostol tablets, Thyroxine 50 mcg, and Misoprostol 100 mcg tablets.
What is the delivery timeline and extension rule for this tender?
Delivery commences from the last date of the original delivery order. If quantity increases under the option clause, additional time equals (extra quantity/original quantity) × original delivery period, with a minimum of 30 days; extensions may be granted up to the original delivery period.
Are there any specific standards or certifications required?
No explicit standards (IS/ISO) are listed in the tender data. Bidders should rely on standard drug regulatory compliance and any final contractual requirements. OEM authorizations may be needed for listed medicines.
What is the estimated value of the pharma procurement in this tender?
The estimated value is ₹40,396.00. This figure indicates a compact, multi-item pharmaceutical procurement package for defense medical needs.
What is the key risk if quantity is varied under the option clause?
The buyer may adjust up to ±25% of the bid quantity at contract placement and during the contract period. Bidders must plan inventory and cash flow to accommodate fluctuating volumes while maintaining delivery timelines.
Explore More Opportunities
Unlock Tender Documents
Sign up now to access all documents
Documents 4
GeM-Bidding-8539889.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS